Candel Therapeutics, Inc. (CADL) vs Mesa Laboratories, Inc. (MLAB)
A side-by-side comparison of Candel Therapeutics, Inc. and Mesa Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CADL
Candel Therapeutics, Inc.
$10.19HealthcareDelayed quote: Oct 6, 2026, 11:55 AM EDT
MLAB
Mesa Laboratories, Inc.
$139.15HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
Total return — CADL vs MLAB
growth of $100 · dividends reinvested · last 5yCADL +46.1% (+7.9%/yr)MLAB -48.4% (-12.4%/yr)CADL compounded faster over this window
CADL MLAB
CADL vs MLAB: by the numbers
- •MLAB is the larger company ($779M vs $747M market cap).
- •MLAB is profitable (1.92% net margin) while CADL runs a net loss (0.00%).
- •MLAB pays a dividend (0.45% yield), while CADL has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CADL | MLAB |
|---|---|---|
| P/E ratio | N/A | 165.65 |
| PEG ratio | N/A | 12.19 |
| P/S ratio | N/A | 3.12 |
| P/B ratio | 5.92 | 4.13 |
| EV / EBITDA | N/A | 18.69 |
| FCF yield | N/A | 6.79% |
Profitability
| Metric | CADL | MLAB |
|---|---|---|
| Gross margin | 0.00% | 65.99% |
| Operating margin | 0.00% | 9.00% |
| Net margin | 0.00% | 1.92% |
| ROE | -70.19% | 2.54% |
| ROIC | -36.83% | 3.29% |
Dividends
| Metric | CADL | MLAB |
|---|---|---|
| Dividend yield | N/A | 0.45% |
| Payout ratio | N/A | 76.19% |
Growth (annualized)
| Metric | CADL | MLAB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.45% |
| EPS CAGR (5Y) | N/A | 13.08% |
| FCF CAGR (5Y) | N/A | 4.63% |
| Total return CAGR (5Y) | -1.42% | -13.52% |
Frequently asked
- Does CADL or MLAB pay a bigger dividend?
- MLAB pays a dividend (0.45% yield), while CADL has no payments in the available dividend history.
- Is CADL or MLAB more profitable?
- MLAB runs the higher net margin — CADL at 0.00% versus MLAB at 1.92%.
- How have CADL and MLAB total returns compared?
- Over the past 5 years, CADL delivered -1.42% and MLAB delivered -13.52% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Mesa Laboratories P/E ratioMesa Laboratories dividend yieldCandel Therapeutics ROEMesa Laboratories ROECandel Therapeutics operating marginMesa Laboratories operating marginCandel Therapeutics revenue growthMesa Laboratories revenue growthCandel Therapeutics free cash flowMesa Laboratories free cash flow
Candel Therapeutics & Mesa Laboratories appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.